
GLP-3 R
1 mg/mLInvestigational metabolic pathway; availability is not promised.
Explore eligibility ↗Shop peptides
Browse therapies that may be available for licensed-clinician consideration through Vale’s clinical and pharmacy partners.
Collection 01
Prescription access, formulation, and fulfillment depend on independent clinical review and current pharmacy availability.

Investigational metabolic pathway; availability is not promised.
Explore eligibility ↗
A prescription GLP-1 option considered within individualized metabolic care.
Explore eligibility ↗
A prescription GIP/GLP-1 option evaluated for eligible patients.
Explore eligibility ↗Collection 02
Prescription access, formulation, and fulfillment depend on independent clinical review and current pharmacy availability.

A peptide option that may be discussed within an appropriate clinical plan.
Explore eligibility ↗
A multi-ingredient formulation subject to clinician and pharmacy availability.
Explore eligibility ↗
A lipotropic-support formulation considered according to individual needs.
Explore eligibility ↗Collection 03
Prescription access, formulation, and fulfillment depend on independent clinical review and current pharmacy availability.

A combined peptide pathway considered only after clinical evaluation.
Explore eligibility ↗
A prescription peptide option that may be evaluated for appropriate candidates.
Explore eligibility ↗
A prescription therapy with suitability determined by a licensed clinician.
Explore eligibility ↗
A combination formulation subject to prescriber and pharmacy review.
Explore eligibility ↗Collection 04
Prescription access, formulation, and fulfillment depend on independent clinical review and current pharmacy availability.

Availability and clinical suitability must be confirmed before ordering.
Explore eligibility ↗
A copper-peptide option considered within a personalized care conversation.
Explore eligibility ↗
A multi-peptide formulation whose ingredients and availability may change.
Explore eligibility ↗
A specialized blend considered only when available and clinically appropriate.
Explore eligibility ↗
A peptide pathway requiring independent clinician review.
Explore eligibility ↗
A combined peptide formulation subject to current pharmacy availability.
Explore eligibility ↗Collection 05
Prescription access, formulation, and fulfillment depend on independent clinical review and current pharmacy availability.

A peptide option discussed within an individualized wellness plan.
Explore eligibility ↗
An injectable antioxidant formulation considered after clinical review.
Explore eligibility ↗
A prescription option evaluated according to health history and goals.
Explore eligibility ↗Collection 06
Prescription access, formulation, and fulfillment depend on independent clinical review and current pharmacy availability.

A longevity-focused peptide pathway subject to availability and eligibility.
Explore eligibility ↗
A mitochondrial peptide option considered within a clinician-led plan.
Explore eligibility ↗
An injectable NAD+ formulation considered based on individual goals.
Explore eligibility ↗
A nasal formulation subject to prescriber and pharmacy availability.
Explore eligibility ↗
A combined peptide pathway requiring licensed clinical review.
Explore eligibility ↗How fulfillment works
Browse by category and begin a private intake when you are ready.
An independent licensed clinician determines whether any treatment is appropriate.
When prescribed, medication is fulfilled by the applicable U.S.-licensed pharmacy.
Reference pricing shown as of August 30, 2026. Final price, formulation, supply duration, and availability must be confirmed with Vale’s clinical and pharmacy partners before launch.
Start with a private health intake. A licensed clinician will review your information and determine whether treatment or testing is appropriate.
Begin private intake ↗